CA988524A - Process for the preparation of 2,6-diamino-1,4-dihydropyridine derivatives - Google Patents

Process for the preparation of 2,6-diamino-1,4-dihydropyridine derivatives

Info

Publication number
CA988524A
CA988524A CA165,209A CA165209A CA988524A CA 988524 A CA988524 A CA 988524A CA 165209 A CA165209 A CA 165209A CA 988524 A CA988524 A CA 988524A
Authority
CA
Canada
Prior art keywords
diamino
preparation
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA165,209A
Other languages
English (en)
Other versions
CA165209S (en
Inventor
Kurt Stoepel
Horst Meyer
Wulf Vater
Friedrich Bossert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA988524A publication Critical patent/CA988524A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CA165,209A 1972-03-06 1973-03-05 Process for the preparation of 2,6-diamino-1,4-dihydropyridine derivatives Expired CA988524A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CA988524A true CA988524A (en) 1976-05-04

Family

ID=5838037

Family Applications (1)

Application Number Title Priority Date Filing Date
CA165,209A Expired CA988524A (en) 1972-03-06 1973-03-05 Process for the preparation of 2,6-diamino-1,4-dihydropyridine derivatives

Country Status (24)

Country Link
JP (2) JPS5626659B2 (OSRAM)
KR (1) KR780000119B1 (OSRAM)
AT (3) AT324338B (OSRAM)
BE (1) BE796279A (OSRAM)
BG (2) BG22815A3 (OSRAM)
CA (1) CA988524A (OSRAM)
CH (2) CH577473A5 (OSRAM)
CS (2) CS182781B2 (OSRAM)
DD (1) DD106833A5 (OSRAM)
DE (1) DE2210687C3 (OSRAM)
DK (1) DK136061C (OSRAM)
ES (1) ES412323A1 (OSRAM)
FI (1) FI55996C (OSRAM)
FR (1) FR2181789B1 (OSRAM)
GB (1) GB1379005A (OSRAM)
HU (1) HU167089B (OSRAM)
IE (1) IE37370B1 (OSRAM)
IL (1) IL41664A (OSRAM)
LU (1) LU67147A1 (OSRAM)
NL (1) NL7303137A (OSRAM)
PL (2) PL92078B1 (OSRAM)
RO (2) RO63068A (OSRAM)
SE (1) SE384208B (OSRAM)
ZA (1) ZA731501B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (OSRAM) * 1985-11-28 1987-06-13
AU2021387535A1 (en) * 2020-11-30 2023-07-06 George Kanianthara Chandy POTENT AND SELECTIVE INHIBITORS OF THE CALCIUM-ACTIVATED POTASSIUM CHANNEL, KCa3.1, FOR USE AS PLATFORM THERAPEUTICS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
DK136061B (da) 1977-08-08
JPS48103579A (OSRAM) 1973-12-25
FR2181789A1 (OSRAM) 1973-12-07
FI55996B (fi) 1979-07-31
FR2181789B1 (OSRAM) 1976-12-03
ZA731501B (en) 1973-11-28
AT324338B (de) 1975-08-25
JPS5911584B2 (ja) 1984-03-16
RO61192A (OSRAM) 1976-09-15
BE796279A (fr) 1973-09-05
CS182792B2 (en) 1978-05-31
JPS5626659B2 (OSRAM) 1981-06-19
LU67147A1 (OSRAM) 1973-05-22
GB1379005A (en) 1975-01-02
DE2210687A1 (de) 1973-09-20
IE37370B1 (en) 1977-07-06
RO63068A (OSRAM) 1978-05-15
DE2210687C3 (de) 1981-09-24
CH580589A5 (OSRAM) 1976-10-15
NL7303137A (OSRAM) 1973-09-10
ES412323A1 (es) 1976-01-01
IL41664A0 (en) 1973-05-31
AT327904B (de) 1976-02-25
DK136061C (da) 1978-01-02
BG20583A3 (bg) 1975-12-05
BG22815A3 (bg) 1977-04-20
IE37370L (en) 1973-09-06
DD106833A5 (OSRAM) 1974-07-05
CH577473A5 (OSRAM) 1976-07-15
JPS5699460A (en) 1981-08-10
KR780000119B1 (en) 1978-04-15
IL41664A (en) 1976-01-30
SE384208B (sv) 1976-04-26
HU167089B (OSRAM) 1975-08-28
ATA925774A (de) 1975-05-15
CS182781B2 (en) 1978-05-31
FI55996C (fi) 1979-11-12
PL89256B1 (OSRAM) 1976-11-30
DE2210687B2 (de) 1980-09-04
PL92078B1 (OSRAM) 1977-03-31

Similar Documents

Publication Publication Date Title
CA1025447A (en) Process for preparing 3,4-dihydrocarbostyril derivatives
CA1005061A (en) Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA1016544A (en) Process for the preparation of bicyclic derivatives of 1,4-dihydropyridine
CA999589A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA989827A (en) Process for the preparation of 14-hydroxymorphinan derivatives
CA983033A (en) 2-amino-1,4-dihydropyridine derivatives
CA1027951A (en) Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
CA999588A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA1027950A (en) Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
CA999869A (en) Process for the preparation of 2-amino-1,4-dihydropyridine derivatives
AU471079B2 (en) 5, 9, 13-prostatrienoic acid derivatives and process for their preparation
CA963469A (en) 3-substituted-as-triazino (5,6,-c) quinoline derivatives and a process for the preparation thereof
CA1023371A (en) Xanthene derivatives and process for the preparation thereof
CA1010036A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA1030151A (en) Process for producing 9,10-seco-oestrane derivatives
CA1003841A (en) 2,10-dichloro-12-methyl-12h-dibenzo(d,g)(1,3)dioxocine derivatives and a process for the preparation of same
CA993871A (en) Process for the preparation of certain indolobenzazepine derivatives
CA1003410A (en) Process for the preparation of alpha-6-deoxytetracyclines
CA998677A (en) Process for the preparation of 2-substituted-1,3,4-thiadiazole-5-thiols
CA1000704A (en) 1,2,3-triazole derivatives and process for preparing them
CA978188A (en) As-triazino(5,6-c)quinoline derivatives and a process for the preparation thereof
CA893126A (en) Process for the production of 1,3,5-triazine derivatives
CA894243A (en) Process for the preparation of 9-pyridylalkyl-1,2,8,9-tetraazaphenale nes
CA1033749A (en) Process for producing 9,10-seco-oestrane derivatives
CA873886A (en) Process for the preparation of 1,3-benzoxazin derivatives